Aims: The study sought to assess the effect of percutaneous pulmonary artery denervation (PADN) on balloon-occlusion-induced acute pulmonary arterial hypertension (PAH) in vivo. The PADN is a minimally invasive and endovascular catheter-based interventional therapy using radiofrequency ablation to abolish the pulmonary arterial baroreceptors to pressure response.
Introduction
Pulmonary arterial hypertension is defined as a group of diseases characterised by a progressive increase in pulmonary vascular resistance resulting in right heart failure and premature death [1] [2] [3] [4] [5] [6] [7] .
Recent therapeutic advances have improved treatment options including prostanoids, endothelin-receptor antagonists and the phosphodiesterase type-5 inhibitors [3] [4] [5] [6] 8, 9 . A meta-analysis of 23 randomised controlled trials demonstrated a reduction in mortality of the patients using the targeted therapies approved for pulmonary arterial hypertension (PAH) 10 . However, there is no cure for PAH and it remains a life-threatening disorder even though these therapies improve symptoms, haemodynamics and outcomes 11 . The pathogenesis of PAH is complicated and still largely unknown. In particular, the role of sympathetic nerve activation remains unsettled 12 .
Historically, several studies have demonstrated that distention and occlusion of one branch of the pulmonary artery by the use of balloons and non-occlusive inflatable cuffed cylinders led to significant increases of pulmonary arterial pressure (PAP) and pulmonary vessel resistance (PVR) [13] [14] [15] [16] [17] [18] . Of note, the increase of PAP and PVR induced by pulmo-pulmonary reflex was confirmed. To clarify the underlying mechanisms involved in this procedure, experimental study showed that pulmonary hypertension may be secondary to the distention of the main pulmonary artery by excitation of stretch receptors in or near the bifurcation area of the main pulmonary artery. In addition, the efferent limb of this reflex was predominantly mediated by the adrenergic nervous system 19 . Based on the evidence mentioned above, we hypothesised that percutaneous catheter-based pulmonary artery denervation (PADN) around the bifurcation area of the main pulmonary artery by radiofrequency ablation might abolish the baroreceptors or sympathetic nervous fibres of the pulmonary artery. Thus, it can be predicted that balloon-occlusion-induced pulmonary arterial pressure increase will be blunted.
Methods

STUDY DESIGN
The study design is shown in Figure 1 . Briefly, twenty Mongolian dogs were randomly assigned to one of two groups: group 1 (left distal pulmonary basal trunk occlusion), and group 2 (left pulmonary interlobar artery occlusion). The occlusion model was conducted by the use of a balloon to stop the distal blood flow completely. Haemodynamic parameters were measured before and after balloon occlusion using a Swan-Ganz pulmonary artery catheter (Baxter Healthcare Corp., Irvine, CA, USA). The effect of PADN treatment at the main pulmonary artery bifurcation level was investigated by repeating the abovementioned procedure followed by left pulmonary interlobar artery occlusion. The study was approved by the Nanjing First Hospital IRB committee (#NJMEDHOS 76895211) and followed the national research council for animal research guidelines.
UNILATERAL PULMONARY ARTERY OCCLUSION AND HAEMODYNAMIC MEASUREMENTS
Sequential unilateral left pulmonary artery occlusion was performed. Briefly, a 6 Fr guiding catheter was engaged in the left pulmonary artery and a pulmonary arteriography was performed (Figure 2A) . A balloon with a diameter of 2.5 mm (8 mm in length) was positioned in the distal pulmonary basal trunk and was inflated at 16 atm for ten minutes in group 1 ( Figure 2B ). In group 2, a balloon with a diameter of 5 mm (8 mm in length) was advanced to the pulmonary interlobar artery, and was inflated at 16 atm for ten minutes ( Figure 2C ). Pulmonary arteriography was performed to confirm the total occlusion of blood flow distal to the balloon. Haemodynamic measurements were performed before, one, two, three, five, and ten minutes after balloon occlusion. A 7 Fr flow-directed Swan-Ganz catheter (Baxter Healthcare Corp.) was inserted percutaneously via the femoral vein for the measurement of resting right atrial pressure (RAP), right ventricular pressure (RVP), systolic/diastolic and mean PAP, pulmonary artery occlusion pressure (PAOP), thermodilution cardiac output (CO), and mixed venous oxygen saturation. PVR=(mean PAP-PAOP)/CO and transpulmonary gradient (TPG)=mean PAP-PAOP were then calculated [20] [21] [22] .
DEDICATED APPARATUS FOR PULMONARY ARTERY HYPERTENSION
A dedicated 7.5 Fr triple-function (mapping, temperature-sensing, and ablation) catheter (PADNTM; Microport Co., Shanghai, China) along an 8 Fr long sheath was advanced beyond the pulmonary valvular level. This catheter has a tapered (to 5 Fr) circular tip with 10 electrodes (each with a width of 0.75 mm and separated by 2 mm, Figure 3A In the present study, after haemodynamic parameters returned to baseline levels, all dogs in both groups (n=20) received the PADN treatment at Level 3 19 . To ensure that the electrodes are tightly contacting the arterial inner surface, three criteria are used as follows:
(1) stronger resistance felt when rotating the handle, (2) inability to advance distally or ease of withdrawing proximally, and (3) angiography confirmation. After the first round of ablation, the catheter tip is withdrawn and rotated and re-advanced to ensure the whole circular axis of the vessel is ablated. The ablation parameters at each point were programmed as: temperature 50°C, energy ≤10 W, impedance <140 Ω, time 20 sec.
STATISTICAL ANALYSIS
All data are expressed as the mean ± SEM of results obtained from the number of experiments. Normal distribution was checked by the Kolmogorov-Smirnov test. Differences between data sets were assessed by paired t-tests or the Wilcoxon rank-sum test. All analyses were undertaken using SPSS 20.0 (IBM Corp., Armonk, 161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204  205  206  207  208  209  210  211  212 NY, USA). A probability value of <0.05 was considered statistically significant (two-sided).
Results
PULMONARY ARTERIAL PRESSURE RESPONSE TO LEFT DISTAL PULMONARY BASAL TRUNK OCCLUSION BY BALLOON INFLATION BEFORE PADN (GROUP 1)
Baseline systolic PAP, mean PAP, and diastolic PAP were 25.7±1.6 mmHg, 14.1±0.7 mmHg, and 8.5±1.2 mmHg, respectively. After balloon occlusion of the left distal pulmonary basal trunk by inflation with a diameter of 2.5 mm, only at three minutes during occlusion, the pulmonary arterial parameters increased statistically compared to the baseline, but the absolute differences Figure 5 ). During continuous occlusion of the left distal pulmonary basal trunk, pulmonary artery occlusion pressure (PAOP), cardiac output (CO), pulmonary vascular resistance (PVR), and heart rate remained stable without significant changes before and during balloon inflation (Table 1) .
PULMONARY ARTERIAL PRESSURE RESPONSE TO LEFT PULMONARY INTERLOBAR ARTERY OCCLUSION BY BALLOON INFLATION BEFORE PADN (GROUP 2)
Baseline systolic PAP, mean PAP, and diastolic PAP were 23.4±0.9 mmHg, 13.9±0.5 mmHg, and 9.6±0.6 mmHg, respectively. During occlusion of the left pulmonary interlobar artery by balloon inflation of a diameter of 5 mm, mean PAP gradually increased and reached peak value (30.5±1.1 mmHg) at five minutes, with absolute PADN treatment for PAH in vivo 213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265 difference of 16.6 mmHg. Between five and ten minutes, increased pulmonary arterial pressure persisted (Figure 6) .
Notably, because there were no significant increases of CO and PAOP, we detected that a significant increment of mean PAP resulted in the higher PVR up to three minutes ( Table 2 ).
PULMONARY ARTERIAL PRESSURE RESPONSE TO LEFT PULMONARY INTERLOBAR ARTERY OCCLUSION BY BALLOON INFLATION AFTER PADN
There were no adverse outcomes and relative complications (death, perforation, acute thrombus formation) pre and post the PADN procedure. The average procedural time was 18.6 minutes. Immediately after the PADN procedure, systolic PAP, mean PAP, and diastolic PAP were 29.8±1.7 mmHg, 16.9±1.5 mmHg, and 12.8±1.7 mmHg, respectively. The peak systolic PAP, mean PAP, and diastolic PAP were observed at three minutes after balloon occlusion. At the five and ten minute time points, there was no significant difference in all of the haemodynamic parameters observed (Figure 7 ). In addition, there was no significant change of PVR between baseline and five minutes (569±330 dye/s/cm 5 vs. 603±258
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Discussion
We hypothesised that experimental pulmonary hypertension can be caused by a reflex mechanism from balloon occlusion of the pulmonary artery. From this experimental study, we reported for the first time that: (1) occlusion of the left pulmonary interlobar artery rather than the left pulmonary basal trunk by balloon inflation induced significant increases of PAP and RVP; (2) PADN at the main bifurcation area of the pulmonary artery using a dedicated ablation catheter might completely abolish the pulmonary artery pressure response to the inflated balloon occlusion.
ACUTE PULMONARY ARTERIAL HYPERTENSION MODEL
According to previous experimental animal models, unilateral pulmonary arterial distention was mainly produced by step-wise inflation of a balloon or by non-occlusive inflatable cuffed cylinders [13] [14] [15] [16] [17] [18] [19] . However, controversy existed about the mechanisms resulting in a significant increase of PAP or PVR. Several studies have shown that the baroreceptors in the pulmonary artery branches contributed to the mediation of PAP but without evidence of stimulation of vagal nerves when blood flow was totally or sub-totally occluded 13, 14 . However, Ueda et al did not find direct evidence of the sympathetic nerves in this pulmo-pulmonary reflex 15 . In another study, Murao et al postulated that this pressure response was solely a mechanical effect involving vasoconstriction 16 . Regardless of the mechanism, the use of the non-occlusive (triple-lumen) balloon distention (step-wise inflation) of the main pulmonary artery at the bifurcation area induced the most significant increases in PAP and PVR 18, 19 . The present study is consistent with previous findings that pulmonary arterial pressure increased significantly using balloon occlusion of the pulmonary artery. This finding represented the fact that acute pulmonary arterial hypertension can be reproduced experimentally and thus it is important to validate the efficacy of the PADN treatment in our study.
BARORECEPTORS AND PULMONARY ARTERIAL HYPERTENSION
Baroreceptors are sensors located in the blood vessels of several mammals: they detect blood pressure and send messages to the central nervous system to increase resistance when necessary 24 . Baroreceptors can be classified as arterial (high-pressure) or venous (low-pressure) 25 . Accumulative evidence implied that the baroreceptors might lie in the main pulmonary artery, probably in or near the bifurcation rather than in the branches themselves. This postulation was examined by Juratsch and colleagues demonstrating that surgical dissection of the areas of the pulmonary artery under the bifurcation and adjacent to the aorta were particularly necessary to abolish the pressure response by balloon inflations 19 . In addition, the sympathetic nerves potentially providing both the afferent and efferent pathways for this reflex were investigated 14, 18, 19 . Efferent sympathetic nerve endings participating in the rise of pressure have been examined by both animal and clinical studies 18, 19, [26] [27] [28] [29] [30] . On the other hand, afferent sympathetic activity originating from the pulmonary artery has been found in the 3 rd and 4 th rami of the spinal cord [31] [32] [33] .
PADN TREATMENT
The sites of the sympathetic nerve endings can also be postulated from our study. A previous study reported that the low-pressure baroreceptors are buried in the pulmonary arterial wall close to the intima
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. However, the high-pressure baroreceptor sensory endings mostly lie in the tunica adventitia of the artery. Thus, it is crucial to remove the adventitia and some portions of the medial layers in order to abolish these baroreceptors. In the present study, PADN treatment completely abolished the pressure response to balloon inflations. Such pressure response, however, was not abolished when PADN was performed in the sites distal (2 mm to 5 mm) to the bifurcation level of the pulmonary artery. This may suggest that the sympathetic nerve endings were localised in or near the area of the bifurcation level of the pulmonary artery.
With the development of sympathetic denervation for the treatment of refractory systemic hypertension by renal ablation denervation technology [34] [35] [36] , we recognised the potential of pulmonary artery denervation for the treatment of pulmonary hypertension. From our experience, there are several limitations of the conventional catheter when used for PADN including: the difficulty of contacting the vessel's inner surfaces tightly, the need for multiple rotations to complete circular ablation, and the high risk of perforation. Thus, we designed a special ablation catheter with a circular tip for this study, where only slight movements were required to keep tight contact with the vessel. As a result, we anticipate that pulmonary artery denervation therapy could be performed safely and successfully. 
Limitations
The study has several limitations. First, the balloon occlusion was not inflated in a step-wise manner. It would have induced vasoconstriction of the pulmonary artery [13] [14] [15] [16] [17] , leading to a rise in both PAP and systolic right ventricular pressure. However, this present study was to examine the effect of PADN on PAP, and did not focus on the mechanisms in the changes of haemodynamics during balloon inflation. Second, the balloon occlusion was repeated after PADN therapy in group 1 and group 2. The tolerance effect of the pulmonary haemodynamics parameters from repeated balloon occlusions was not assessed. Third, there was an absence of histological evidence from the PADN treatment in our study. The lack of histological proof of sympathetic nerve damage weakened our hypothesis of damaged nerve endings by our ablation techniques. However, the safety of the PADN treatment was approved, as no experimental dogs died after the PADN treatment. Finally, the current study only reported that PADN treatment abolished the acute experimental pulmonary hypertension. The effect of PADN treatment in chronic pulmonary hypertension or irreversible condition remains unsettled. Further experimental studies will address the details of precise mechanisms and different settings with respect to the PADN treatment. As a result of the safety and efficacy of PADN treatment in the present study, a FIM study is expected to be organised in the near future.
Conclusions
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